"NEN Treatments: Focus On DLL3" with Dr. Rohit Thummalapalli

"NEN Treatments: Focus On DLL3" with Dr. Rohit Thummalapalli

ABOUT THIS EPISODE DLL3 is emerging as a promising new target for neuroendocrine cancers. In this episode, Dr. Rohit Thummalapalli, medical oncologist at Memorial Sloan Kettering Cancer Center, explains what DLL3 is, how it works, who might benefit, and what current clinical trials are teaching us. He breaks down the science, treatment options, and future directions in a way that is clear, approachable, and designed to help patients and families better understand this developing area of care....

Avsnitt(50)

Episode 32: Focus on Somatostatin Analogues (SSAs)

Episode 32: Focus on Somatostatin Analogues (SSAs)

How do SSAs work? Should all NET patients be on one? What are the side effects? Dr. Edward Wolin from Mount Sinai Health System answers several common questions about the current and future role of somatostatin analogues in NET treatment. MEET Dr. EDWARD M. WOLIN Professor of Medicine, Medical Oncology, Icahn School of Medicine Director, Center for Carcinoid and Neuroendocrine Tumors Tisch Cancer Institute, Mount Sinai Health System Dr. Edward M. Wolin is an internationally renowned a...

30 Apr 202453min

Episode 31: (Part I) Clinical Trials - Expectations vs. Realities

Episode 31: (Part I) Clinical Trials - Expectations vs. Realities

In this two-part series, we reprise “Navigating Clinical Trials: Expectations vs. Realities” with Taymeyah Al-Toubah. This was previously broadcast on August 19th, 2023, as a LACNETS monthly educational webinar. In Part 1, Taymeyah discusses clinical trial terminology, timeline, questions to ask, and misconceptions. In Part 2, Taymeyah answers questions about logistics and practical aspects of clinical trials, such as costs, response time, and follow-up. She also answers frequently asked ques...

14 Mars 202435min

Episode 31: (Part II) Clinical Trials - Expectations vs. Realities

Episode 31: (Part II) Clinical Trials - Expectations vs. Realities

In this two-part series, we reprise “Navigating Clinical Trials: Expectations vs. Realities” with Taymeyah Al-Toubah. This was previously broadcast on August 19th, 2023, as a LACNETS monthly educational webinar. In Part 1, Taymeyah discusses clinical trial terminology, timeline, questions to ask, and misconceptions. In Part 2, Taymeyah answers questions about logistics and practical aspects of clinical trials, such as costs, response time, and follow-up. She also answers frequently asked ques...

14 Mars 202440min

Episode 30: Bone & Brain Metastases in Neuroendocrine Cancer

Episode 30: Bone & Brain Metastases in Neuroendocrine Cancer

When and how often do NETs spread to the bones or brain? How are they found? What is the treatment? Dr. Robert Ramirez of Vanderbilt University addresses concerns surrounding bone metastases (or “mets”) as well as rare brain metastases. MEET DR. ROBERT RAMIREZ, DO, FACP Dr. Robert Ramirez is a medical oncologist specializing in the treatment of thoracic and neuroendocrine malignancies and an Associate Professor of Medicine at Vanderbilt University Medical Center in Nashville, TN.&nbs...

15 Feb 202443min

Episode 29: "Nutrition & Diet Considerations for NET" with Sina Teskey

Episode 29: "Nutrition & Diet Considerations for NET" with Sina Teskey

NET dietician Sina Teskey from the Medical College of Wisconsin answers common questions about diet and nutrition raised among NET patients and caregivers. She addresses special diets, food restrictions, and whether sugar “feeds” cancer. Sina also speaks to diarrhea, and digestive enzymes and shares tips on how to maintain nutrition and weight. MEET SINA TESKEY, RD, CD Sina Teskey, RD, CD received her B.S. from the University of Wisconsin-Madison in 2006 and completed her dietetic internsh...

15 Jan 202445min

Top 10 Highlights of 2023 NANETS Symposium

Top 10 Highlights of 2023 NANETS Symposium

In this special episode, Oregon Health & Sciences University (OHSU) Medical oncologist, Dr. Guillaume (Will) Pegna, recaps the North American Neuroendocrine Tumor Society (NANETS) 2023 Multidisciplinary NET Medical Symposium. He shares the latest developments in NET research and medical advances from the conference and discusses why they matter to the NET patient community. MEET DR. GUILLAUME PEGNA Dr. Pegna is a medical oncologist who specializes in the care of adults with neuroendocr...

11 Dec 20231h

Episode 27: What to Know About Neuroendocrine Tumor Liver Metastases

Episode 27: What to Know About Neuroendocrine Tumor Liver Metastases

What do you call NETs in the liver? How often do NETs spread? What causes NETs to spread? How do you determine if surgery is an option? Dr. Xavier Keutgen from University of Chicago brings clarity to NET tumors found in the liver and describes how surgery fits in with other treatments for metastatic NETs. ABOUT DR. XAVIER KEUTGEN Xavier M. Keutgen MD is a board-certified, double-fellowship trained surgeon who specializes in the treatment of gastro-entero-pancreatic neuroendocrine tumors and ...

15 Nov 202346min

Episode 26: What to Know About Lung NETs

Episode 26: What to Know About Lung NETs

What are lung NETs? What is DIPNECH? How is lung NET similar or different from lung cancer? Dr. Vineeth Sukrithan from Ohio State University Comprehensive Cancer Center gives a comprehensive overview of lung NET and DIPNECH, including the work-up and treatment options. He also discusses open clinical trials and exciting advances in lung NET research on the horizon. For more information, visit LACNETS.org/podcast/24. For more information, visit LACNETS.org. For more information, visit N...

15 Okt 202344min

Populärt inom Utbildning

rss-bara-en-till-om-missbruk-medberoende-2
historiepodden-se
det-skaver
sektledare
nu-blir-det-historia
alska-oss
harrisons-dramatiska-historia
allt-du-velat-veta
johannes-hansen-podcast
not-fanny-anymore
roda-vita-rosen
rss-sjalsligt-avkladd
i-vantan-pa-katastrofen
rikatillsammans-om-privatekonomi-rikedom-i-livet
rss-max-tant-med-max-villman
sa-in-i-sjalen
handen-pa-hjartat
dumforklarat
nar-man-talar-om-trollen
rss-pa-insidan-med-bjorn-rudman